Clinical trial Recruiting at 2 sites Observational Ages Any age to 6 Months

Study of factors influencing celiac disease in infants

Official title: Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) Study

Run by Massachusetts General Hospital · NCT02061306 · Data updated 2026-11-12

This study is trying to see how genetics and environmental factors affect the risk of celiac disease in infants who have a family member with the condition.

More Celiac Disease trials

Quick facts

Study typeObservational
AgesAny age to 6 Months
SexAll
Enrollment500 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedMarch 2014
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedOctober 30, 2026
Trial IDNCT02061306 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are newborns and infants under six months of age with a first-degree relative diagnosed with celiac disease.

Probably not a fit

Infants older than six months or those without a family history of celiac disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CDGEMM study investigates the interplay of genomic, environmental, microbiome, and metabolomic factors in the development of celiac disease (CD) among infants. It focuses on newborns with a first-degree relative diagnosed with CD, examining how genetic predispositions and environmental influences, such as birth method and antibiotic use, contribute to disease risk. The study will follow these infants until they are five years old, collecting data on their health and dietary habits to identify potential predictors of CD. By understanding these factors, the study aims to enhance early detection and prevention strategies for high-risk children.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention and early detection strategies for celiac disease in high-risk infants.

How similar studies have gone: Other studies have shown success in identifying genetic and environmental factors related to celiac disease, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Newborns and infants less than 6 months of age who have not been introduced to solid foods (exclusive breast milk or formula diet)
* First-degree relatives of patients affected with biopsy-proven CD

Exclusion Criteria:

* Infants older than 6 months of age
* Inability or unwillingness of legal guardian/representative to give written informed consent

Where it's running

  • MassGeneral Hospital for Children
    Boston, Massachusetts, United States
    Recruiting
  • University of Roma La Sapienza
    Rome, Italy
    Recruiting

Study contacts

  • Principal investigator: Maureen Leonard, MD — Massachusetts General Hospital
  • Study coordinator: Victoria Kenyon, MHA
  • Email: vakenyon@mgb.org
  • Phone: 617-643-4366

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.